Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2019-05-07 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
关于使用部分闲置募集资金进行现金管理到期赎回的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding the use of idle raised funds for cash management and the maturity redemption of related financial products. It references prior approvals by the board and shareholders, compliance with regulatory guidelines, and details about the investment and its returns. The document is relatively short (1516 characters) and primarily serves to inform about the status and results of a specific financial activity related to fundraising proceeds. It does not contain comprehensive financial statements or detailed financial analysis. It also references other announcements for more details. Therefore, this document is best classified as a Capital/Financing Update (CAP), as it updates on the use and management of raised funds and related financial activities.
2019-05-07 Chinese
华西证券股份有限公司关于公司首次公开发行并上市持续督导保荐总结报告书
Regulatory Filings Classification · 95% confidence The document is titled as a "持续督导保荐总结报告书" which translates to a "Continuous Supervision Sponsorship Summary Report" related to the initial public offering (IPO) and listing of a company. It references regulatory approvals from the China Securities Regulatory Commission (CSRC) and Shenzhen Stock Exchange, and details the sponsorship and supervision activities performed by the sponsoring securities firm during the IPO and post-IPO period. The document includes descriptions of due diligence, ongoing supervision, compliance with disclosure obligations, and fundraising usage review. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement or certification. Instead, it is a detailed summary report by the sponsor on their continuous supervision duties post-IPO, which fits the category of Regulatory Filings (RNS) as it is a regulatory compliance document that does not fit other specific categories such as Annual Report or Capital/Financing Update. The document length is under 5,000 characters, but it contains substantive content rather than just an announcement of a report publication, so it is not RPA. Therefore, the best classification is Regulatory Filings (RNS).
2019-05-07 Chinese
关于举行2018年度网上业绩说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about holding an online performance explanation meeting (业绩说明会) related to the 2018 annual report. It mentions that the full 2018 annual report has already been disclosed and provides details about the upcoming online meeting for investors to understand the company's performance better. The document is short (671 characters) and serves as a notice for the event rather than containing the actual annual report or detailed financial data. Therefore, it is best classified as an Investor Presentation (IP) since it focuses on a presentation event for investors about financial results and company performance.
2019-04-30 Chinese
关于参加2019年西藏辖区上市公司投资者集体接待日的公告
Investor Presentation Classification · 90% confidence The document is a short announcement (702 characters) about the company's participation in an investor collective reception day event organized by a regional stock association and a network company. It mentions the event date and the topics to be discussed, including the 2018 annual report, governance, strategy, financing plans, and sustainability. However, the document itself does not contain any financial data or the report itself; it is an announcement of an investor event where such topics will be discussed. The document length and content indicate it is not a full report but an announcement related to investor relations. Therefore, it fits best under Investor Presentation (IP) as it is a detailed presentation for investors focusing on financials, strategy, and market position, albeit in a live event format.
2019-04-30 Chinese
关于延期召开2018年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice from a company about the postponement of its 2018 Annual General Meeting (AGM). It details the change in the meeting date, confirms that other meeting details remain unchanged, and references a previous announcement about the AGM. The document does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is an announcement related to the AGM event itself, specifically about the scheduling change. Therefore, it fits the category of AGM Information (AGM-R). The document length is short (1381 characters), consistent with an announcement rather than a full report.
2019-04-30 Chinese
2019年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 First Quarter Report" of 西藏易明西雅医药科技股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as income, profit, cash flow, assets, liabilities, and explanations for changes in financial indicators. The length of the document (7681 characters) and the presence of substantive financial statements and analysis confirm it is a comprehensive interim report rather than a brief announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-25 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.